ROR1 and its role in CLL and other cancers
Promising results for venetoclax combination therapies in elderly AML
Can venetoclax be used to treat multiple myeloma (MM)?
Should we use the word 'cure' in CLL?
Combinations with FLT3 inhibitors: the way forward for AML treatment